Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells.

PLoS One · 2019 · PMC6592550 · PMID 31237925

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

failed to reach statistical significanceno p-value reported

This trial failed to reach statistical significance, however, a clear trend towards improved response rates and prolonged median progression-free survival (mPFS) of combined SSA treatment + VEGF inhibition compared to monotherapy SSA was observed.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.